CapsulesCapsules
Schedule H (Prescription Required)NSAIDs & Pain ReliefCode: 513

Piroxicam Capsules 20 mg

Generic Formulation:Piroxicam Capsules IP 20 mg
Pack Size:10's
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹8.44
Brand Estimate*
₹66.42
Estimated Savings:₹57.98 (87% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Piroxicam Capsules / Dispersible Tablets (10mg, 20mg) is an oral oxicam-class non-steroidal anti-inflammatory drug on the WHO Model List of Essential Medicines. Characterized by a very long elimination half-life (~50 hours), allowing once-daily dosing. Dispersible tablets disintegrate rapidly in water for easy administration. Indicated for symptomatic relief of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 513.Report inaccuracy

Usage Guidelines

Take orally 20 mg once daily after a meal with a full glass of water. Dispersible tablets: Disperse the tablet in a tablespoon (at least 10 mL) of water and swallow immediately. Swallow capsules whole.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Dyspepsia, nausea, abdominal discomfort, diarrhea, flatulence, dizziness, headache. Rare/Severe: Highest rate of serious gastrointestinal ulceration and bleeding among traditional NSAIDs, severe cutaneous adverse reactions (toxic epidermal necrolysis, SJS), and nephrotoxicity.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Black Box Warning: Highest risk of serious gastrointestinal toxicity and severe life-threatening cutaneous reactions (SJS/TEN) among NSAIDs. Second-line therapy only; do NOT use as initial treatment. Discontinue immediately at first sign of skin rash or mucous membrane lesions. Contraindicated in elderly patients with peptic ulcer history.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or analgesic treatment guidance. Always consult a registered physician or orthopedic specialist before taking pain relievers, anti-inflammatory medications, or anti-arthritic therapies.